High levels of ZAP70 and CD38 are associated with reduced survival in CLL patients, especially in those with unmutated IGHV, and CD38 positivity is frequently found in combination with anemia, thrombocytopenia, and leukocytosis (19). This evidence concerns the gene ZAP70 and Thrombocytopenia.